Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1058715

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 February 2019 to Question 213200 on Air Pollution and with reference to p165 of the World Health Organisation report, Review of evidence on health aspects of air pollution – REVIHAAP Project, if his Department will conduct research into PM1 and PM0.1.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	219268
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, but no separate assessments of the impact of PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns respectively) of particulate air pollution have been produced.</p><p> </p><p>Public Health England (PHE) undertakes various air quality research projects, working with academic partners, to review the evidence of the health effects of air pollutants. In particular, regarding the health effects of PM0.1 and PM1, PHE has a research program that looks at various aspects of the health effects of PM0.1 (nanoparticles) through the inhalational route mainly focussed on manufactured materials. However, PHE has no plans to engage in work on the effects of PM1 particles on human health over the coming year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219269 question first answered 19/02/2019 17:29:50 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1058716

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 February 2019 to Question 213200 and with reference to page six of the January 2013 report of the Health Effects Institute entitled Understanding the Health Effects of Ambient Ultrafine Particles, if he will implement the recommendations of that report on PM0.1 and PM1.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	219269
answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, but no separate assessments of the impact of PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns respectively) of particulate air pollution have been produced.</p><p> </p><p>Public Health England (PHE) undertakes various air quality research projects, working with academic partners, to review the evidence of the health effects of air pollutants. In particular, regarding the health effects of PM0.1 and PM1, PHE has a research program that looks at various aspects of the health effects of PM0.1 (nanoparticles) through the inhalational route mainly focussed on manufactured materials. However, PHE has no plans to engage in work on the effects of PM1 particles on human health over the coming year.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 219268 question first answered 19/02/2019 17:29:50 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

1058750

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	UK Antimicrobial Resistance Diagnostics Collaborative
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) representations his Department has received on the work of the UK Antimicrobial Resistance (AMR) Diagnostics Collaborative and (b) discussions have taken place between his Department and members of that group; what the timetable is for the publication of the AMR Diagnostics Collaborative's report; and (c) if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	219373
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>Over the last five years, implementation of the United Kingdom antimicrobial resistance (AMR) strategy has been overseen and driven by a cross-Government High Level Steering Group, chaired by the Chief Medical Officer for England.</p><p> </p><p>Professor Dame Sue Hill, Chief Scientific Officer for NHS England, leads work to deliver the Government’s ambitions for diagnostics as part of the strategy. NHS England established the UK AMR Diagnostics Collaborative to support delivery of the United Kingdom’s diagnostics ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostics elements of the new UK five-year national action plan on AMR, published in January this year.</p><p> </p><p>The Department continues to work closely with the UK AMR Diagnostics Collaborative, which currently has no plans to publish a report.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:44:29 answering member 4067 label Biography information for Steve Brine
tabling member	1604 label Biography information for Mr Virendra Sharma

1058752

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the implications for his Department's policies of the findings of the National Aids Trust report, Drug-Related Deaths in England, published by the National Aids Trust, published on 5 February 2019; and if he will make a statement.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	219400
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>No formal assessment has been made of the National AIDS Trust report however officials will consider its findings in the development of future drugs policy. The Government is concerned by the number of drug-related deaths and is supporting local areas to develop a more joined up approach to commissioning and delivering the range of services that are essential to supporting recovery and preventing drug-related deaths.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:45:27 answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1058753

registered interest
date	11/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the proposed amendments to the Human Medicines Regulation 2012, what treatment areas will be excluded from the serious shortage protocol for reasons of patient safety; and if he will publish a list of medicines and formulations that will be excluded as a result.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	219427
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>As the explanatory memorandum of the amending Statutory Instrument acknowledges, protocols for therapeutic or generic equivalents will not be suitable for all medicines and patients. For example, such protocols would not be suitable for medicines that need to be prescribed by brand for clinical reasons, such as biological medicines. In these cases, patients would always be referred to the prescriber for any decision about their treatment before any therapeutic or generic alternative is supplied.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:35:25 answering member 4067 label Biography information for Steve Brine
tabling member	4127 label Biography information for Julie Elliott

1057004

registered interest
date	08/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if the Government will commit to fully funding the Workforce Implementation Plan to tackle shortages in the breast cancer workforce.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	218843
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key National Health Service interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including the breast cancer workforce, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:30:42 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith

1057018

registered interest
date	08/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that every patient with pancreatic cancer receives treatment within the first 20 days of diagnosis.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	218748
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The information is not available in the format requested.</p><p> </p><p>Clinical priority remains the main determinant of when a patient should be treated.</p><p> </p><p>NHS England will shortly be introducing a new Faster Diagnostic Standard for all cancer patients, including those with suspected pancreatic cancer, which will see patients given a diagnosis or the all clear within 28 days. The 31-day standard of decision to treat to undergoing first treatment will remain in place. However, this is an upper limit and clinical priority will always remain the main determinant of when a patient should be treated.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218749 question first answered 18/02/2019 17:29:51 answering member 4067 label Biography information for Steve Brine
tabling member	298 label Biography information for Steve McCabe

1057020

registered interest
date	08/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many pancreatic cancer patients received treatment within 20 days of diagnosis in each of the last five years.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	218749
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The information is not available in the format requested.</p><p> </p><p>Clinical priority remains the main determinant of when a patient should be treated.</p><p> </p><p>NHS England will shortly be introducing a new Faster Diagnostic Standard for all cancer patients, including those with suspected pancreatic cancer, which will see patients given a diagnosis or the all clear within 28 days. The 31-day standard of decision to treat to undergoing first treatment will remain in place. However, this is an upper limit and clinical priority will always remain the main determinant of when a patient should be treated.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 218748 question first answered 18/02/2019 17:29:51 answering member 4067 label Biography information for Steve Brine
tabling member	298 label Biography information for Steve McCabe

1057021

registered interest
date	08/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government has made an assessment of the level of funding required by Cancer Alliances to deliver the policies set out in the NHS Long Term Plan.
tabling member constituency	Mitcham and Morden
tabling member printed	Siobhain McDonagh
uin	218743
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Cancer Alliances will work with their sustainability and transformation plans/integrated care systems to develop local plans that set out how they will direct local funding to deliver the cancer ambitions in the NHS Long Term Plan. Cancer Alliances will receive funding to support the transformation required to address the priorities for their local populations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:16:22 answering member 4067 label Biography information for Steve Brine
tabling member	193 label Biography information for Dame Siobhain McDonagh

1057028

registered interest
date	08/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incinerators: Air Pollution
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 February 2019 to Question 213202 on Incinerators: Air Pollution, with reference to the report entitled Ultrafine Particulates (UFP) in the UK, published by the Air Quality Expert Group by his Department in 2018, if he will make an assessment of the effect of ultrafine particles on human health (a) in and (b) outside of the vicinity of incinerators.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	218744
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The Air Quality Expert Group Report on ‘Ultrafine Particles in the UK’ summarised current knowledge on the levels, sources and characteristics of ultrafine particles in the United Kingdom air; the report can be viewed at the following link:</p><p> </p><p><a href="https://uk-air.defra.gov.uk/library/reports.php?report_id=968" target="_blank">https://uk-air.defra.gov.uk/library/reports.php?report_id=968</a></p><p> </p><p>An assessment on the potential health impacts of ultrafine particles was beyond the scope of this report.</p><p> </p><p>Reviews by the Health Effects Institute and World Health Organization of the effects of different components of air pollution, including ultrafine particles (PM<sub>0.1</sub>), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reports are available to view at the following links:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Public Health England has no plans to engage in work on the effects of ultrafine particles on human health in and outside the vicinity of incinerators.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:27:43 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew